Lowenthal Alexander, Evans Jasmine M A, Punn Rajesh, Nourse Susan E, Vu Chau N, Popat Rita A, Selamet Tierney Elif Seda
Division of Pediatric Cardiology, Department of Pediatrics, Stanford University, Lucile Packard Children's Hospital, Palo Alto, California;
Division of Epidemiology, Stanford University, Palo Alto, California.
Am J Hypertens. 2014 Sep;27(9):1218-24. doi: 10.1093/ajh/hpu034. Epub 2014 Mar 13.
Aortic pulse wave velocity (PWV) and augmentation index (AIx) are markers of vascular health and have recently been used in pediatric clinical trials. However, there are limited data on standardization of these measurements in pediatrics. The objective of this study was to prospectively test the feasibility and reproducibility of PWV and AIx in children and adolescents.
We performed arterial tonometry on 2 different days within 2 weeks in 40 healthy subjects aged 10-19 years. PWV and AIx were measured in triplicate on each visit.
The visits were separated by a mean of 3.08±3.7 days. We obtained PWV in 77 of 80 (96%) visits and AIx in 76 of 80 (95%) visits in triplicate. Intraclass correlation coefficients (ICCs) for PWV were 0.61 (95% confidence interval (CI) = 0-0.86) when at least 2 measurements and 0.92 (95% CI = 0-1) when 3 measurements were obtained at each visit that met the quality criteria established for adults by the manufacturer (n = 17 and 3 paired visits, respectively). For AIx, ICCs were 0.78 (95% CI = 0.58-0.88) and 0.81 (95% CI = 0.63-0.90) when measurements with an operator index ≥80, a measure of the quality of the waveform, were included (n = 39 and 36 paired visits, respectively).
Arterial applanation tonometry is feasible and reproducible in healthy children and adolescents. AIx has excellent intervisit reproducibility, whereas the intervisit reproducibility of PWV relies on acquisition of multiple measurements that meet quality criteria established for adults. These results have implications for the methodology of future pediatric clinical trials in a population at increasingly higher risk for premature atherosclerosis.
主动脉脉搏波速度(PWV)和增强指数(AIx)是血管健康的标志物,最近已用于儿科临床试验。然而,关于这些测量在儿科的标准化数据有限。本研究的目的是前瞻性地测试儿童和青少年中PWV和AIx测量的可行性和可重复性。
我们在2周内的2个不同日期对40名年龄在10 - 19岁的健康受试者进行了动脉张力测量。每次就诊时对PWV和AIx进行三次测量。
两次就诊之间的平均间隔为3.08±3.7天。我们在80次就诊中的77次(96%)获得了PWV的三次测量值,在80次就诊中的76次(95%)获得了AIx的三次测量值。当每次就诊至少获得2次测量值时,PWV的组内相关系数(ICC)为0.61(95%置信区间(CI)= 0 - 0.86),当每次就诊获得3次符合制造商为成人设定的质量标准的测量值时,ICC为0.92(95% CI = 0 - 1)(分别为n = 17次和3对就诊)。对于AIx,当纳入操作员指数≥80(波形质量的一种度量)的测量值时,ICC分别为0.78(95% CI = 0.58 - 0.88)和0.81(95% CI = 0.63 - 0.90)(分别为n = 39次和36对就诊)。
动脉压平式张力测量在健康儿童和青少年中是可行且可重复操作的。AIx具有出色的就诊间可重复性,而PWV的就诊间可重复性依赖于获取符合为成人设定的质量标准的多次测量值。这些结果对未来针对动脉粥样硬化过早发病风险日益增加人群的儿科临床试验方法具有重要意义。